# BALPHARMA — Bal Pharma Limited

> Bal Pharma Limited (BALPHARMA) on the NSE: 4,947 sessions of split-adjusted history from 2006.

Canonical: https://patternsradar.com/s/BALPHARMA

## Latest session

- Close: 85.93 INR (-0.84% on the day), 2026-08-21
- Delivery: 80.32% of volume taken to demat (20-day average 65.1%)
- Volume: 9.0K shares, turnover ₹7.7L
- Relative volume: 0.36× of its own 20-day average

## Technicals

- RSI(14): 48.05
- ATR(14): 3.28
- SMA 50: 85.63, SMA 200: 77.92
- 52-week range: 60 – 98.85 (-13.07% from the high)

## Performance

- 1 week -1.29%, 1 month -2.78%, 3 months 4.75%
- 6 months 13.02%, 1 year -5.79%

## Fundamentals

- Market cap: 136.8 crore
- P/E (TTM): 18.87 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 4.55 INR, split-adjusted to match the price series
- Revenue growth: 34.53% YoY, 5.4% QoQ
- Profit growth: 445.66% YoY, -68.43% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | -1.29% | -2.4% |
| 3y | 3.14% | 43.97% |
| 4y | 4.52% | 13.68% |
| 6y | 11.5% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 73.7 | 72.1 | 1.4 | 1 | 0.65 | 1.41% |
| 2024-12-31 | 73.2 | 73.1 | 0.6 | 0.5 | 0.33 | 0.71% |
| 2025-03-31 | 81.9 | 80.4 | 2.6 | 5.4 | 3.4 | 6.57% |
| 2025-06-30 | 65.9 | 66.4 | 0.2 | 0.2 | 0.13 | 0.32% |
| 2025-09-30 | 74 | 74.4 | 0.7 | 0.7 | 0.45 | 0.97% |
| 2025-12-31 | 87.7 | 86.2 | 1.8 | 1.8 | 1.12 | 2.04% |
| 2026-03-31 | 84.1 | 80.6 | 3.2 | 3.6 | 2.26 | 4.29% |
| 2026-06-30 | 88.6 | 87.9 | 1.1 | 1.1 | 0.71 | 1.28% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 50.86%
- Public: 49.14%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-12: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_186000_12082026183710_iXBRL_WEB.html
- 2026-07-13: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1691250_13072026011426_WEB.xml
- 2026-05-27: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_162033_27052026173635_iXBRL_WEB.html
- 2026-04-08: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1647275_08042026031036_WEB.xml
- 2026-02-11: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142035_11022026182410_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1680659_10062026024318_WEB.xml
- 2025-11-12: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_126699_12112025184104_iXBRL_WEB.html
- 2025-10-10: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1544451_10102025043804_WEB.xml

Dated by the day the company broadcast the filing. 126 events are indexed for this instrument.

## About the instrument

- Listed: 2006-05-08 — latest session 2026-08-21 (4,947 sessions)
- ISIN: INE083D01012
- Series: EQ
- Liquidity rank: #1957 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/BALPHARMA.